DPP-4 inhibitors A variety of DPP-4 inhibitors are available, differing in dosing frequency, metabolism, and excretion pathways, allowing for individualized selection based on renal function, liver function, and lifestyle considerations in individuals with type 2 diabetes (Fig
View supplementary YouTube videos on Administering Intramuscular Injections: Z-Track Method [14] [14] Ventrogluteal Injection [15] [15] This work is a derivative of Clinical Procedures for Safer Patient Care by British Columbia Institute of Technology and is licensed under CC BY 4.0 This work is a derivative of Clinical Procedures for Safer Patient Care by British Columbia Institute of Technology and is licensed under CC BY 4.0 by British Columbia Institute of Technology is licensed under CC BY 4.0
Such collaborative care models, which may involve dietitians, physical therapists, and pharmacists, enhance patient education and foster adherence to the prescribed GLP-1 regimen, ultimately supporting better health outcomes
Despite extensive research highlighting their neuroprotective, antioxidant, anti-inflammatory, antibacterial, dermatological, antitumor, and antidiabetic properties, the underlying mechanisms remain only partially understood
Weeks 1-4: Initiation Phase During the first month, Retatrutide effects dominate